Anti-SARS-CoV-2 Spike Glycoprotein RBD antibody [2G1]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal SPIKE antibody. Suitable for ICC/IF, WB and reacts with Transfected cell line - SARS-CoV-2, Recombinant full length protein - SARS-CoV-2, Transfected cell lysate - SARS-CoV-2 samples. Cited in 4 publications. Immunogen corresponding to Recombinant Fragment Protein within SARS-CoV-2 S.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SARS-CoV-2 Spike Glycoprotein RBD antibody [2G1] (AB277624)
HEK-293 cells transfected with the DNA encoding the S-protein segment stained for spike glycoprotein using ab277624 (green) at 1/1000 dilution in Immunocytochemistry. The nuclei of transfected and untransfected cells are shown in blue with DAPI DNA stain.
- WB
Supplier Data
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein RBD antibody [2G1] (AB277624)
Western blot analysis of cells transfected with DNA encoding the S-protein ACE2 binding site in PROT-SARS-CoV2-bd which was inserted into pCI-Neo-Mod or pCI-Neo-GFP eukaryotic expression vectors, which express either the insert only or the insert fused with GFP using ab277624 (green) at 1/3000 dilution. The blot was also stained with rabbit polyclonal control antibody to HSP60 (red) at 1/5000 dilution.
Lanes 1 and 5:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein RBD antibody [2G1] (ab277624)
Lanes 2, 3, 4, 6 and 7:
Western blot - Anti-SARS-CoV-2 Spike Glycoprotein RBD antibody [2G1] (ab277624) at 1/3000 dilution
Lanes 1 and 5:
Molecular weight ladder
Lane 2:
crude homogenate of untransfected control HEK-293 cells
Lane 3:
homogenate of HEK-293 cells expressing SARS-CoV2-bd
Lane 4:
homogenate of HEK-293 cells expressing GFP-SARS-CoV2-bd fusion
Lane 6:
full length recombinant SARS-CoV2 S-protein expressed in HEK293 at 1 µg
Lane 7:
full length recombinant SARS-CoV2 S-protein expressed in HEK293 at 0.1 µg
Observed band size: 60 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SARS-CoV-2 Spike Glycoprotein RBD initiates attachment to host cells by specifically binding to the ACE2 receptor facilitating viral entry. The RBD is part of a larger trimeric complex where each monomer consists of an S1 and S2 domain. The S1 domain which includes the RBD is important for receptor binding while the S2 domain aids in membrane fusion. By mediating these initial interactions with host cells the RBD dictates the entry and infectivity of the virus.
Pathways
The interaction of the SARS-CoV-2 RBD with ACE2 is an important event in the entry pathways of the virus. This interaction triggers a cascade of events leading to endocytosis and viral replication. The virus utilizes the cellular machinery by hijacking the ACE2-mediated entry pathway which involves proteolytic processing by transmembrane protease serine 2 (TMPRSS2). The RBD's role connects closely with these proteins playing a vital part in both viral fusion and endocytosis pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
CNS neuroscience & therapeutics 30:e14822 PubMed38923860
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinica chimica acta; international journal of clinical chemistry 542:117279 PubMed36871661
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:827146 PubMed35320941
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:803647 PubMed35095889
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com